Series U funding round for Alladapt Immunotherapeutics raising $120M in June 2022
Series U funding round for Alladapt Immunotherapeutics raising $120M in June 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Patrick S. Chung |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$180M
Top Valuation
-
Alladapt Immunotherapeutics raised $120M in a Series U round.
The round was announced on 06/01/22.